persona-tomsk.ru


Emmaus Life Sciences Stock

Research Emmaus Life Sciences' (OTCPK:EMMA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. Emmaus Life Sciences' stock was trading at $ at the start of the year. Since then, EMMA shares have increased by % and is now trading at $ View. Emmaus went public on July 18, following a stock-for-stock merger with MYnd Analytics, Inc. The merger became effective following approval by Emmaus' and. View today's Emmaus Life Sciences Inc stock price and latest EMMA news and analysis. Create real-time notifications to follow any changes in the live stock. Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for.

Emmaus Life Sciences Incorporation ; Price. Price ; Market. All; Market ; Line. Line; Area; OHLC. TORRANCE, Calif., March 23, /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA) a commercial-stage biopharmaceutical company and leader in the. Created with Highstock Price FrequencyM Mar 1 Mar 5 Feb 29 1D; 5D; 1M; 3M; 6M; 1Y; 2Y; 3Y; 5Y; 10Y; 20Y. Detailed Information. Today. View EMMAUS LIFE SCIENCES INC NEW (EMMA) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Emmaus Life Sciences's market cap is million.. View Emmaus Life Sciences, Inc.'s Market Cap trends, charts, and more. On Friday, Emmaus Life Sciences Inc (EMMA:QXR) closed at , % above the 52 week low of set on Dec 20, week range. Today. Dec Discover real-time Emmaus Life Sciences Incorporation (EMMA) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Emmaus Life Sciences Incorporation - EMMA STOCK NEWS ; 11/14/ AM · Emmaus Life Sciences Reports Q3 Financial Results ; 08/23/ AM · Emmaus. Emmaus Life Sciences Incorporation stock forecast, EMMA price prediction: Buy or sell Emmaus Life Sciences, Inc. shares? EMMA Price is USD today. 1. Information on stock, financials, earnings, subsidiaries, investors, and executives for Emmaus Life Sciences. Use the PitchBook Platform to explore the full. The aggregate market value of shares of common stock held by non-affiliates of the registrant as of June 30, , the last business day of the registrant's.

PROFILE (EMMA). Emmaus Life Sciences, Inc. operates as a biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative. EMMA | Complete Emmaus Life Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Complete Emmaus Life Sciences Inc. stock information by Barron's. View real-time EMMA stock price and news, along with industry-best analysis. Prev. Close. ; 52wk Low. ; Market Cap. k ; Total Shares. m ; Shares Out. m. Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative. View EMMAUS LIFE SCIENCES INC NEW (EMMA) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Stock analysis for Emmaus Life Sciences Inc (EMMA:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company. Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative. Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies.

Emmaus Life Sciences is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Emmaus Life was actively. Emmaus Life Sciences Inc EMMA:OTCQX ; Last | 03/08/24 EDT. quote price arrow down (%) ; Volume. 1, ; 52 week range. - Emmaus Life Sciences, Inc. engages in the discovery, development, and commercialization of treatments and therapies primarily for rare and orphan diseases. Emmaus Life Sciences is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Emmaus Life was actively. Emmaus Life Sciences (OTC: EMMA) · Emmaus Life Sciences Return vs. S&P · Emmaus Life Sciences Company Info · News & Analysis · Financial Health · Valuation.

Emmaus Life Sciences reveals new Phase 3 data of its drug Endari in sickle cell patients

Medical · Medical - Biomedical and Genetics, $B ; Emmaus Life Sciences Inc. is a commercial-stage biopharmaceutical company. Emmaus Life Sciences Inc. is a commercial-stage biopharmaceutical company. It is engaged in the discovery, development, marketing and sale of treatments and. Emmaus Life Sciences Stock (OTC: EMMA) stock price, news, charts, stock research, profile. Emmaus Life Sciences, Inc. (US:EMMA) has 2 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission. Company profile for Emmaus Life Sciences, Inc. (EMMA) with a description, list of executives, contact details and other key facts.

line friends | coinbase nucypher

29 30 31 32 33

Copyright 2015-2024 Privice Policy Contacts SiteMap RSS